1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250...

112
1

Transcript of 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250...

Page 1: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

1

Page 2: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

2

Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year.

I can’t see in dim light.

Page 3: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

3

Our body can synthesize vitamin A from beta-carotene.

Page 4: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

4

Scientists have successfully transferred the genes for producing beta-carotene from maize and bacteria to rice plants.

genes

Page 5: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

5

The resultant Golden Rice can produce high levels of beta-carotene in its grains.

Page 6: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

6

A Swiss scientist developed transgenic golden rice rich in iron and vitamin A, two major nutrient deficiencies in developing countries where the major staple food is rice. This involved genetically engineering 3 proteins and the vitamin precursor β-carotene from 4 different species.

Page 7: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

7

What are the advantages of geneticengineering over traditional breeding in crop improvement

1

Page 8: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

8

2.1 Biotechnology in medicine

• human insulin

Production of pharmaceutical products

• human growth hormone• vaccines• monoclonal antibodies (單克隆抗體 )

similar processes

Page 9: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

9

1 Human growth hormone (HGH)• secreted from the pituitary gland

2.1 Biotechnology in medicine

• important in development of bones and muscles

• deficiency:

Page 10: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

10

• HGH was extracted from the pituitary gland of dead people

2.1 Biotechnology in medicine

limited supply

1 Human growth hormone (HGH)

contaminated with pathogens

Page 11: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

11

2.1 Biotechnology in medicine

1 Human growth hormone (HGH)• recombinant HGH

unlimited amount

pure

low cost

Page 12: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

12

2.1 Biotechnology in medicine

1 Human growth hormone (HGH)• bacteria are commonly used

- provide plasmids that act as vectors

- serve as host cells

- can be transformed easily

- can grow rapidly

- can grow in inexpensive culture media

- relatively stable culture

Page 13: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

13

2 Vaccines• antigenic proteins can be produced by

recombinant DNA technology

2.1 Biotechnology in medicine

e.g. vaccines against hepatitis B

Page 14: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

14

Prepare a recombinant plasmid

2.1 Biotechnology in medicine

2 Vaccines

gene for viral surface protein

plasmid

Page 15: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

15

Introduce the recombinant plasmid into a yeast cell

2.1 Biotechnology in medicine

2 Vaccines

yeast cell

Page 16: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

16

Culture GM yeast on a large scale

2.1 Biotechnology in medicine

2 Vaccines

Page 17: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

17

According to the genetic information of the viral gene, the GM yeast produces the viral surface protein

2.1 Biotechnology in medicine

2 Vaccines

Page 18: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

18

The viral surface protein is collected and purified for use

2.1 Biotechnology in medicine

2 Vaccines

Page 19: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

19

2 Vaccines• traditional hepatitis B vaccines contain

the whole viruses

2.1 Biotechnology in medicine

viruses may become active and infectious

• recombinant hepatitis B vaccines contain only a viral surface protein

safer to use

Page 20: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

20

Principle of EdibleEdible vaccine

Page 21: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

21

3 Monoclonal antibodies• antibodies produced by the cell clones

derived from a single parent B cell

2.1 Biotechnology in medicine

• highly specific

Page 22: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

22

"magic bullet" monoclonal antibody1. myeloma cells –

keeing dividing--immortal

2. fuse with healthy antibody-producing B-cells

3. Hybridomas produced

4. select hybridomas cells with specific antibodies

5. Grow in culture

6. Harvest monoclonal antibodies

Page 23: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

23

3 Monoclonal antibodiesi) For diagnosis of diseases

2.1 Biotechnology in medicine

• recognize the surface proteins of cancer cells in tissue samples

Page 24: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

24

3 Monoclonal antibodiesii) For developing sensitive tests

2.1 Biotechnology in medicine

• home pregnancy tests• bind to human chorionic gonadotrophin

(HCG) in urine

Page 25: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

25

Application of monoclonal antibodies:

Pregnancy testing kit

Page 26: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

26

3 Monoclonal antibodiesiii) For isolating and purifying

important biological molecules

2.1 Biotechnology in medicine

• specific to the molecule of interest

Page 27: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

27

3 Monoclonal antibodies• Drawback of

monoclonal antibodies produced using B cells from mice

2.1 Biotechnology in medicine

could stimulate an immune response in humans Results in their rapid removal from the blood, inflammatory effects, and the production of human anti-mouse antibodies

Page 28: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

28

In vitro / Recombinant Monoclonal antibodies:

2.1 Biotechnology in medicine

less likely to be destroyed in the human body

a human antibody with a small part of a mouse monoclonal antibody

Made by merging mouse DNA encoding the binding portion of a monoclonal antibody with human antibody-producing DNA in living cells, and the expression of this hybrid DNA through cell culture yielded partially mouse, partially human monoclonal antibody.

Page 29: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

29

3 Monoclonal antibodies• recombinant monoclonal antibodies

2.1 Biotechnology in medicine

• used in the treatment of some forms of cancer- linked with a toxic drug

or a radioactive substance –magic bulletmagic bullet

Page 30: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

30

Gene therapy• to treat a disease by supplementing the

defective gene with a normal gene

2.1 Biotechnology in medicine

• vectors for transferring a normal gene into a target celle.g. harmless viruses

Page 31: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

31

Diagram of the human chromosome set, showing the location of some genes whose mutant forms can cause hereditary diseases. Conditions that can be diagnosed using DNA analysis are indicated by a red dot. 

Page 32: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

32

Gene therapy• ex vivo (先體外後體內 ) gene therapy:

2.1 Biotechnology in medicine

cells are genetically modified outside the body and then put back into the patient

Page 33: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

33

Gene therapy with a retrovirus

Page 34: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

34

Gene therapy• in vivo (體內 ) gene

therapy:

2.1 Biotechnology in medicine

cells are genetically modified inside the body

vectors with normal genes

direct transfer of normal genes into cells

Page 35: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

35

Page 36: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

36

Cystic fibrosis (CF), the most common lethal, single-gene disorder affecting Northern Europeans and North Americans, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Page 37: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

37

Gene therapy• germ line gene therapy (種系基因治療 ) :

2.1 Biotechnology in medicine

corrects the genetic material of gametes or zygotes

• genetic correction is inheritable• done on animals only

Page 38: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

38

Gene therapy• somatic cell gene therapy (體細胞基因治療 ) :

2.1 Biotechnology in medicine

corrects the genetic material of somatic cells

• genetic correction is not inheritable• all human trials are of this type

Page 39: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

39

Gene therapy

• treat genetic diseases, cancer and infectious diseases

2.1 Biotechnology in medicine

• as a preventive measure against diseases• correct a disease before it develops and help remove all the defective genes in the human population

Potential benefitsPotential benefits

Page 40: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

40

Gene therapy

• viral vectors cause diseases

2.1 Biotechnology in medicine

• viral vectors cause severe immune reactions

• insertion of new genes affects the expression of existing genes

Potential hazardsPotential hazards

Page 41: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

41

Gene therapy

• new genes wrongly transported into non-target cells, produce too much of the missing protein or produce the protein at the wrong time

2.1 Biotechnology in medicine

Potential hazardsPotential hazards

Page 42: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

42

Risks involved in gene therapy• in an attempt experiment to treat

Ornithine transcarbamylase deficiency by gene therapy, a patient died in 1999.

• The patient was injected with adenoviruses carrying a corrected gene in the hope that it would manufacture the needed enzyme.

• He died four days later, apparently having suffered a massive immune response triggered by the use of the viral vector used to transport the gene into his cells.

Page 43: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

43

Risks involved in gene therapy• in an attempt experiment to treat

Ornithine transcarbamylase deficiency by gene therapy, a patient died in 1999.

• The patient was injected with adenoviruses carrying a corrected gene in the hope that it would manufacture the needed enzyme.

• He died four days later, apparently having suffered a massive immune response triggered by the use of the viral vector used to transport the gene into his cells.

Page 44: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

44

.

• tampering with human genes might lead to the practice of eugenics, a deliberate effort to control the genetic makeup of human populations.

• The most difficult ethical question is whether we should treat human germ-line cells to correct the defect in future generations.

• we will have to face the question of whether it is advisable, under any circumstances, to alter the genomes of human germ lines or embryos. Should we interfere with human evolution in this way?

Gene therapy poses many ethical and social questions

Gene therapy poses many ethical and social questions

Page 45: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

45

Stem cell therapy2.1 Biotechnology in medicine

• unspecialized cells

• unlimited mitotic cell division

• can differentiate into different kinds of cells

• Embryonic stem cells /Adult stem cells

• Differs in their “potency”

• unspecialized cells

• unlimited mitotic cell division

• can differentiate into different kinds of cells

• Embryonic stem cells /Adult stem cells

• Differs in their “potency”

Page 46: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

46

totipotent, pluripotent, multipotent?

Page 47: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

47

totipotent, pluripotent, multipotent?

• TotipotentTotipotent cells can form all the cell types in a body, plus the extraembryonic, or placental, cells. Embryonic cells within the first couple of cell divisions (8-cell stage) after fertilization are the only cells that are totipotent.

• PluripotentPluripotent cells can give rise to all of the cell types that make up the body. e.g. embryonic stem cells (16-cell stage).

• MultipotentMultipotent cells can develop into more than one cell type, but are more limited than pluripotent cells; adult stem cells and cord blood stem cells, peripheral blood stem cells are considered multipotent.

Page 48: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

48

Stem cell therapy2.1 Biotechnology in medicine

embryonic stem cells

• from blastocysts

• can differentiate into almost any cell types

(Pluripotent)

embryonic stem cells

• from blastocysts

• can differentiate into almost any cell types

(Pluripotent)

Page 49: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

49

After fertilization, the zygote undergoes cleavage:the first few mitotic divisions multiply the total number of cells without increasing total mass.The ball of cells that implants in the uterus is a blastocyst, and contains the inner cell mass, where embryonic stem cells can be harvested.

Page 50: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

50

Stem cell therapy2.1 Biotechnology in medicine

adult stem cells

• from childhood or adult tissues like bone marrow, blood, skeletal muscles

• can only differentiate into a limited range of cell types “Multipotent” or unipotent

adult stem cells

• from childhood or adult tissues like bone marrow, blood, skeletal muscles

• can only differentiate into a limited range of cell types “Multipotent” or unipotent

Page 51: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

51

Stem cell therapy2.1 Biotechnology in medicine

• stem cells may be used to replace damaged or abnormal cells in the treatment of diseasese.g. blood stem cells in bone marrow and in

peripheral blood, cord blood (臍帶血 ) containing blood stem cells are used in the treatment of blood diseases (multipotent)

Page 52: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

52

Stem cell therapy2.1 Biotechnology in medicine

e.g. human embryonic stem cells

human blastocyst

isolate embryonic stem cells

cultured embryonic stem cells

Page 53: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

53

Stem cell therapy2.1 Biotechnology in medicine

e.g. human embryonic stem cells

induce the cells to differentiate into specific cell types

insulin-producing cells• for treating type 1 diabetes

Page 54: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

54

Stem cell therapy2.1 Biotechnology in medicine

e.g. human embryonic stem cells

induce the cells to differentiate into specific cell types

cardiac muscle cells• for treating heart disease

Page 55: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

55

Stem cell therapy2.1 Biotechnology in medicine

e.g. human embryonic stem cells

induce the cells to differentiate into specific cell types

neurones• for treating spinal cord injuries,

Parkinson’s disease

Page 56: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

56

• Since the regrown cells originate from the patient, there should be no immune rejection of the transplanted tissue.

Stem cell therapy / stem cell cloning

Page 57: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

57

Stem cell therapy2.1 Biotechnology in medicine

• isolation of embryonic stem cells involves destruction of human embryos

controversial• adult stem cells occur in low number,

are difficult to isolate and can only differentiate into a limited range of cell types

Page 58: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

58

Stem cell therapy2.1 Biotechnology in medicine

• human skin cells were successfully re-programmed to become unspecialized cells in 2007 – IPS cells

Nobel Prize in physiology or

medicine (2012)

Page 59: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

59

Stem cell therapy2.1 Biotechnology in medicine

may act as a limitless source of immune-compatible cells for transplantation

• human skin cells were successfully re-programmed to become unspecialized

cells in 2007 –IPS cells

Page 60: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

60

Sources of stem cells (1) human embryos

Page 61: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

61

Sources of stem cells (2) IPS – induced pluripotent stem cells

Page 62: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

62

Sources of stem cells (2) IPS – induced pluripotent stem cells

Page 63: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

63

Page 64: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

64

Applications of IPS cells

Page 65: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

65

Stem cell therapy2.1 Biotechnology in medicine

• questions to be answered

How can we induce embryonic stem cells to differentiate into

each of the desired cell types?

Page 66: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

66

Stem cell therapy2.1 Biotechnology in medicine

• questions to be answered

Are re-programmed cells safe to use in therapy?

How long can the transplanted cells last in the body?

Page 67: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

67

1 Some examples of pharmaceutical products using biotechnology include human insulin, human growth hormone, and vaccines

.monoclonal antibodies

2.1 Biotechnology in medicine

Page 68: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

68

2 Monoclonal antibodies are antibodies produced by theclones

derived from a single parent B cell.

2.1 Biotechnology in medicine

cell

Page 69: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

69

3 is to treat a disease by supplementing the defective gene with a normal gene.

2.1 Biotechnology in medicine

Gene therapy

Page 70: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

70

4

2.1 Biotechnology in medicine

gene therapy

gene therapy

Affects gametes and zygotes

Affects somatic cells

Genetic correction is inheritable

Genetic correction is not inheritable

Germ line Somatic cell

Page 71: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

71

a It may treat genetic diseases, cancer and infectious diseases.

5 Potential benefits of gene therapy:

preventive

2.1 Biotechnology in medicine

b It may be used as a measure against diseases.

Page 72: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

72

c It may correct a disease before the disease develops in the individuals and help remove all the in the human population.

5 Potential benefits of gene therapy:

defective genes

2.1 Biotechnology in medicine

Page 73: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

73

a Viral vectors may gain the ability to cause diseases during modification.

6 Potential hazards of gene therapy:

immune reactions

2.1 Biotechnology in medicine

b Viral vectors may cause severe.

Page 74: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

74

c The insertion of new genes may affect the of existing genes.

6 Potential hazards of gene therapy:

2.1 Biotechnology in medicine

expression

Page 75: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

75

d The new genes may be wrongly transported into cells. They may also produce too much of the missing protein or produce the protein at the wrong time. This results in other health problems.

6 Potential hazards of gene therapy:

2.1 Biotechnology in medicine

non-target

Page 76: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

76

e The patient is repeatedly exposed to possible hazards when

6 Potential hazards of gene therapy:

2.1 Biotechnology in medicine

repeated gene therapy is required.

Page 77: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

77

7 Stem cells may be used in the treatment of type diabetes, heart disease, muscular dystrophy,

2.1 Biotechnology in medicine

1

spinal cord injuries, Parkinson’s disease, etc.

Page 78: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

78

2.2 Biotechnology in agriculture

• organisms whose genetic material has been altered through genetic engineering

What are transgenic organisms?

Golden Rice

Page 79: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

79

• transgenic organisms are useful in scientific research

for the study of gene functions

2.2 Biotechnology in agriculture

as disease models

for toxicity tests for new products

Page 80: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

80

Transgenic plants in agriculture and the food industry• many transgenic plants are major crops

2.2 Biotechnology in agriculture

soya bean (52%)

maize (31%)

cotton (12%)

canola (5%)

Page 81: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

81

Transgenic plants in agriculture and the food industry

• introduce genes for improving the yields or nutritional value of crops

2.2 Biotechnology in agriculture

• many transgenic plants are major crops

for food use and as parents in traditional breeding

Page 82: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

82

2.2 Biotechnology in agriculture

1 Herbicide resistant soya beans and maize

• weeds can be killed by herbicide

Page 83: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

83

2.2 Biotechnology in agriculture

2 Pest resistant maize and cotton

• toxin is pest-specific• reduces the use of chemical pesticides

Page 84: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

84

2.2 Biotechnology in agriculture

3 Disease resistant papayas

• prevents crops from being damaged by diseases

• reduces the use of chemical pesticides

viral resistant non-transgenic

Page 85: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

85

• crops can be grown in winter, dry climates and on saline lands

2.2 Biotechnology in agriculture

4 Rice, wheat and tomatoes tolerant to cold, drought or high salinity of soil

Page 86: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

86

2.2 Biotechnology in agriculture

5 Tomatoes with a longer shelf life

• reduces the loss of fruits• fruits of better quality

non-transgenic

transgenic

Page 87: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

87

2.2 Biotechnology in agriculture

6 Soya beans, canola and rice with improved nutritional value

• higher levels of ‘good’ lipids help prevent heart disease

Page 88: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

88

2.2 Biotechnology in agriculture

• higher levels of beta-carotene, vitamin E, iron, zinc or lysine prevent dietary deficiencies

6 Soya beans, canola and rice with improved nutritional value Animation

Page 89: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

89

Transgenic animals in agriculture and the food industry• introduce genes for improving the

productivity and quality of farm animals

2.2 Biotechnology in agriculture

Page 90: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

90

2.2 Biotechnology in agriculture

1 Fast-growing salmon

• decreases overfishing of wild salmon

non-transgenic transgenic

Page 91: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

91

2.2 Biotechnology in agriculture

2 Cold resistant salmon• expands the area for fish farming

3 Transgenic pigs that produce more lean tissue and less fat

• improves human health

Page 92: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

92

2.2 Biotechnology in agriculture

4 Transgenic goats that produce milk with improved composition and production

• produces lactose-free milk suitable for people who cannot tolerate lactose

Page 93: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

93

2.2 Biotechnology in agriculture

4 Transgenic goats that produce milk with improved composition and production

• produces milk with a lower level of ‘bad’ lipids which is healthier for the heart

Page 94: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

94

2.2 Biotechnology in agriculture

4 Transgenic goats that produce milk with improved composition and production

• increases milk production

Page 95: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

95

2.2 Biotechnology in agriculture

5 Transgenic sheep that produce more wool of better quality

• improves the quality of wool• increases wool production

Page 96: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

96

2.2 Biotechnology in agriculture

6 Transgenic pigs that produce 60% less phosphorus in their manure

• reduces pollution caused by manure

Page 97: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

97

1 are organisms whose genetic material has been altered through genetic engineering.

Transgenic organisms

2.2 Biotechnology in agriculture

Page 98: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

98

a They are used for the study of

2 Uses of transgenic plants and animals in scientific research:

gene

b They act as models.

2.2 Biotechnology in agriculture

functions.

disease

c They are used for tests for new products.

toxicity

Page 99: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

99

• resistance to herbicides,

3 Examples of desirable characteristics built into transgenic plants:

diseases

2.2 Biotechnology in agriculture

andcold drought

pests

• tolerance to , or high salinity of soil

Page 100: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

100

• delayed or

3 Examples of desirable characteristics built into transgenic plants:

2.2 Biotechnology in agriculture

nutritional value

softening• improved

ripening

Page 101: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

101

• improved meat or milk

• resistance

• faster growth

4 Examples of desirable characteristics built into transgenic animals:

cold

2.2 Biotechnology in agriculture

andcomposition production

Page 102: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

102

• manure with low levels of

• improved wool quality and production

4 Examples of desirable characteristics built into transgenic animals:

phosphorus

2.2 Biotechnology in agriculture

Page 103: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

103

a Transgenic plants and animals with improved productivity and quality are produced. They may provide a more reliable

5 Uses of transgenic plants and animals in agriculture:

2.2 Biotechnology in agriculture

foodsupply for all people.

Page 104: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

104

b They can be used as in traditional breeding.

5 Uses of transgenic plants and animals in agriculture:

2.2 Biotechnology in agriculture

parents

Page 105: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

105

c They can help protect the environment by reducing the use of chemical or producing less polluting .

5 Uses of transgenic plants and animals in agriculture:

2.2 Biotechnology in agriculture

pesticidesmanure

Page 106: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

106

In addition to beta-carotene, whatother useful products can be produced from genetic engineering?

1

Human insulin, human growth factor, vaccines and monoclonal antibodies can be produced from genetic engineering.

Page 107: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

107

What are the advantages of geneticengineering over traditional breeding in crop improvement?

2

Genetic engineering provides a quicker and more precise method to modify the genetic make-up and hence the characteristics of crops.

Page 108: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

108

What are the advantages of geneticengineering over traditional breeding in crop improvement?

2

It also allows the transfer of new characteristics from completely non-related species.

Page 109: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

109

applications in medicine include

Biotechnology

production of pharmaceutical

products

gene therapy

stem cell therapy

Page 110: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

110

examples

production of pharmaceutical products

human insulin

human growth hormone

vaccinesmonoclonal antibodies

Page 111: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

111

gene therapy

divided into

germ line gene therapy

somatic cell gene therapy

Page 112: 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year. I can’t see in dim light.

112

used to produce Biotechnology

productivity quality

transgenic plants and animals

used in agriculture to improve